Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34078449

about

Safety of dipeptidyl peptidase 4 inhibitors: a perspective review Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists The efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjects Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.Mechanisms of current therapies for diabetes mellitus type 2 Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.Treating the obese diabetic.Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis.Comparison of charges and resource use associated with saxagliptin and sitagliptin.Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials.Tackling dipeptidyl peptidase IV in neurological disorders.

P2860

Q26863262-36748A52-D69C-491E-90DB-FD8C2F3B2CA3 Q28077026-D9470520-F018-4D32-8E0D-67267CBD163C Q35166849-1A5596DA-ED63-4169-BA5E-50C772259EC3 Q36523427-1F909468-B9B3-49D7-A640-BDEA4BBFB70A Q37180829-7A2268BC-3CFC-44CD-86CA-D6E799360426 Q37737474-6D805D25-7520-4BCA-8574-77C635525577 Q38087696-64C6412F-73AB-42AA-819C-9FA70B13BFCA Q38101993-691C1584-401E-44E4-86C2-0283BDADDCD6 Q38889402-5240CB47-8020-4800-A6C4-982B798CA2D2 Q40382798-8A490F17-E7DF-4B7C-AE5C-FA8EC66CF535 Q49940117-EC34B66E-65D9-413A-896C-BCE246D4B3B1

P2860

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34078449

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@ast

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@en

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@nl

type

label

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@ast

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@en

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@nl

prefLabel

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@ast

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@en

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@nl

P1433

Q34078449-1AB2CB02-9F02-400E-AA40-0654785FE999

P1476

Q34078449-300F5958-78AD-49E0-ADC8-B0F811885CC5

P2093

Q34078449-2E24A1DB-3797-42E8-A1A9-D6FAAAB49CAC

Q34078449-3E780B8B-0672-48BB-8B62-EF6BC3BA0A1B

Q34078449-67565325-63F0-4B60-9602-3B183E3D7771

Q34078449-D2B03714-A668-45B4-9CA7-1C318C3B5A0A

Q34078449-E9E12D08-52E8-4C64-A2C7-5654078A770B

P2860

Q34078449-00A7EDD7-A566-4728-AB5D-F7A808521811

Q34078449-063B33FE-23CA-4D85-A46D-A1C15156B2ED

Q34078449-100E8588-5F1E-4065-97AD-16B19C3C8380

Q34078449-142B99D9-77B5-4166-8863-A1ED84C5F7FB

Q34078449-223B2293-BBB0-441A-A707-8C301F843C30

Q34078449-24836858-1A66-4A89-A256-FD8CDDA63A6A

Q34078449-2B1B591D-E447-4A4D-8913-E97A6F3C8D17

Q34078449-2FD908D7-FD87-4827-B6B9-503BC42FC2CF

Q34078449-348F23D3-8022-45FF-A84C-38C886C8D3E3

Q34078449-37AB2B95-7C8D-4FE2-89FD-565744A69742

P304

Q34078449-257BCD1F-A1D0-41AC-B6DE-A48DB147E4DC

P31

Q34078449-54972d4b-b066-4370-b2dd-a7de7ed15b66

Q34078449-76DE633D-C6ED-4420-B6A1-B092806F09CB

P356

Q34078449-81A2498F-949A-4E50-ACB1-144324CC5525

P433

Q34078449-2748441A-4E1B-4FAC-92F1-85DA0288043B

P478

Q34078449-D35EC3B2-BF37-463D-A4A1-A31D6CBB98F7

P577

Q34078449-EED27D0F-AA2E-41B8-889A-6DD0C02DC5DF

P698

Q34078449-A4CCD78C-89F3-490D-9CD6-C05B25824CB7

P921

Q34078449-43C5B1D1-52F1-4F19-B285-CC212F41F472

Q34078449-74272F54-F382-442B-9EB4-D3CC66BE9B99

P356

J.1463-1326.2011.01540.X

P1433

Diabetes, Obesity and Metabolism

P1476

Saxagliptin and sitagliptin in ...... atic review and meta-analysis.

@en

P2093

D E Jonas

http://www.w3.org/2001/XMLSchema#string

E Van Scoyoc

http://www.w3.org/2001/XMLSchema#string

Katherine R Gerrald

http://www.w3.org/2001/XMLSchema#string

R C Wines

http://www.w3.org/2001/XMLSchema#string

T Runge

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Standards of medical care in diabetes--2010.

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Current methods of the US Preventive Services Task Force: a review of the process.

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.

AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program.

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.

P304

481-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1463-1326.2011.01540.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22098472

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes